Zelma Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 28-05-2024
- Paid Up Capital ₹ 0.10 M
as on 28-05-2024
- Company Age 9 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 93.55%
(FY 2022)
- Profit 134.62%
(FY 2022)
- Ebitda 204.49%
(FY 2022)
- Net Worth 73.22%
(FY 2022)
- Total Assets -40.51%
(FY 2022)
About Zelma Lifesciences
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Gagandeep Kaur and Harsimran Tuli serve as directors at the Company.
- CIN/LLPIN
U24232CH2015PTC035465
- Company No.
035465
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Mar 2015
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, Chandigarh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Zelma Lifesciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gagandeep Kaur  | Director | 20-Mar-2015 | Current |
| Harsimran Tuli | Director | 20-Mar-2015 | Current |
Financial Performance of Zelma Lifesciences.
Zelma Lifesciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 93.55% increase. The company also saw a substantial improvement in profitability, with a 134.62% increase in profit. The company's net worth Soared by an impressive increase of 73.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zelma Lifesciences?
In 2020, Zelma Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Zelma Lifesciences?
Unlock and access historical data on people associated with Zelma Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zelma Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zelma Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
